Online Cognitive Behavioural Therapy for Insomnia
(e-COSMOS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests an online program designed to assist older adults with sleep issues and mental health concerns like anxiety and depression. The program, called Online Cognitive Behavioural Therapy for Sleep and Mental Health, provides weekly sessions that participants can complete independently, aiming to improve sleep quality, mental health, and cognitive abilities. Ideal participants are those aged 60 or older who have trouble sleeping and experience some cognitive challenges, and they must be comfortable using the internet and a smartphone or tablet. As an unphased trial, this study offers participants a unique opportunity to contribute to innovative research that could enhance mental health care for older adults.
Will I have to stop taking my current medications?
The trial requires that if you are on hypnotic or psychotropic medication (including cannabis), you must be on a stable dosage for at least 2 months before joining. If you are taking these medications, you won't need to stop, but you must not change the dosage.
What prior data suggests that this online cognitive behavioral therapy is safe for older adults with insomnia and subjective cognitive complaints?
Research shows that online cognitive behavioral therapy for insomnia is generally safe. Studies have found that digital CBT-I can significantly improve sleep quality and reduce insomnia symptoms. It often serves as the first choice for treating long-term insomnia in adults, indicating it is usually well-received.
Serious side effects from online therapy like this are rare. Most people experience only mild and short-term issues, such as slight increases in anxiety or frustration. These typically resolve after a few sessions as users become more comfortable with the program.
Overall, the safety record for digital CBT-I is positive. Participants can expect a safe experience with the potential for better sleep and improved mental well-being.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential of online cognitive behavioral therapy (CBT) to improve sleep and mental health in older adults. Unlike traditional in-person CBT, this treatment is delivered online through 10 self-directed modules, providing flexibility and accessibility for participants. This method could be particularly beneficial for older adults who may face mobility issues or live in remote areas. Additionally, the trial includes a comparison with an online intervention focusing on nutrition and communication, which could help in understanding the broader benefits of online behavioral interventions for mental health and cognitive issues. Ultimately, this trial could pave the way for more accessible mental health care solutions tailored to the needs of older adults.
What evidence suggests that this online cognitive behavioral therapy is effective for insomnia?
Research has shown that cognitive behavioral therapy for insomnia (CBT-I) effectively improves sleep issues. In this trial, one group of participants will receive online cognitive behavioral therapy for insomnia, anxiety, and depression. One study found that digital CBT-I not only reduced insomnia symptoms but also helped with depression and anxiety. Another study demonstrated that CBT-I effectively aids those with both insomnia and mental health conditions like depression or PTSD. Doctors often recommend this therapy as the first choice for treating insomnia. It uses techniques to help individuals fall asleep faster and stay asleep longer. Overall, CBT-I has a strong history of improving sleep and reducing anxiety or depression.678910
Are You a Good Fit for This Trial?
This trial is for adults aged 60 or older who have trouble sleeping (insomnia) and feel their memory isn't as good as it used to be. They should be able to read French or English, use a smartphone or tablet, and have internet at home. If they're taking sleep or mood medications, the dose must have been the same for at least two months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 10 weeks of online cognitive-behavioral therapy or control intervention
Monitoring
Participants complete sleep diaries, wear actigraphy devices, and undergo cognitive testing
Follow-up
Participants are monitored for changes in sleep and cognitive performance
What Are the Treatments Tested in This Trial?
Interventions
- Online COgnitive Behavioural Therapy for Sleep and Mental Health for Older Adults With Insomnia and Subjective Cognitive Complaints
Trial Overview
The study tests an online program that combines cognitive-behavioral therapy with education on nutrition and communication aimed at improving sleep, anxiety, depression, and cognitive abilities in older adults with insomnia and self-perceived memory issues.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
10 self-directed modules of cognitive behavioral therapy for insomnia, anxiety and depression, delivered online, once a week
10 self-directed modules on healthy nutrition habits and communication strategies, delivered online, once a week
Online COgnitive Behavioural Therapy for Sleep and Mental Health for Older Adults With Insomnia and Subjective Cognitive Complaints is already approved in United States, European Union for the following indications:
- Insomnia
- Depression
- Anxiety
- Insomnia
- Depression
- Anxiety
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Lead Sponsor
Published Research Related to This Trial
Citations
Home | SAMHSA - Substance Abuse and Mental Health ...
SAMHSA leads efforts to advance behavioral health across the U.S., offering resources for mental health, substance use, and community well-being.
Cognitive Behavioral Therapy for Insomnia (CBT-I): A Primer
CBT-I is a multi-component treatment for insomnia that targets difficulties with initiating and/or maintaining sleep and is delivered over the course of six to ...
Cognitive behavioral therapy for insomnia in patients with ...
CBT-I is an effective treatment for patients with insomnia and a comorbid mental disorder, especially depression, PTSD and alcohol dependency.
Digital cognitive behavioral therapy for insomnia on ...
The results demonstrated that digital intervention for insomnia yielded significant effects on alleviating depressive and anxiety symptoms as well as insomnia ...
The applicability and effectiveness of the cognitive ...
Cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment, but the existing CBT-I ignores the intervention for anxiety-depressive symptoms, ...
Digital cognitive behavioral therapy for insomnia on ...
A meta-analysis found that internet-based CBT-I had significantly improved insomnia severity and sleep parameters in addition to comorbid ...
Internet-delivered Cognitive Behavioral Therapy for Insomnia
Sleepio is a CBTI-based digital sleep treatment tool that uses artificial intelligence to analyze users' sleep data and provide personalized ...
Digital cognitive behavioral therapy for insomnia
The AASM recommends clinicians use cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment for chronic insomnia in adults.
Digital Cognitive Behavioral Therapy vs Medication ...
In this study, clinical evidence suggested that combination therapy was optimal, and dCBT-I was more effective than medication therapy, with long-term benefits ...
Assessing the Short-Term Efficacy of Digital Cognitive ...
The outcomes included measures of insomnia (the ISI and the Sleep Condition Indicator), mood disturbances, fatigue, daytime sleepiness, quality ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.